Sinopharm Hyundai announced that it is expected to achieve net profit of 320 million yuan to 340 million yuan in the first quarter of 2024, an increase of 78.55% to 89.71% over the previous year.
国药现代：2024年第一季度净利润预增78.55%到89.71%
Sinopharm Hyundai: Net profit increased 78.55% to 89.71% in the first quarter of 2024
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.